Clinical and clinicopathologic effects of plateletpheresis on healthy donor dogs

Transfusion

Volumn 48, Issue 10, 2008, Pages 2214-2221

  Callan, Mary Beth ^a   Appleman, Elizabeth H ^b   Shofer, Frances S ^b   Mason, Nicola J ^b   Brainard, Benjamin M ^b   Groman, Reid P ^b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACID CITRATE DEXTROSE; CALCIUM; CALCIUM ION; CITRIC ACID; ELECTROLYTE; GLUCONATE CALCIUM; MAGNESIUM; THROMBOCYTE CONCENTRATE;

ANIMAL EXPERIMENT; ARTICLE; BLOOD CELL COUNT; BLOOD DONOR; BLOOD PRESSURE MEASUREMENT; BLOOD SAMPLING; CLINICAL ASSESSMENT; DOG; ELECTROCARDIOGRAPHY; FEMALE; HEART VENTRICLE EXTRASYSTOLE; HYPOTENSION; MALE; MEASUREMENT; NONHUMAN; SAFETY; THROMBOCYTOPHERESIS; TREMOR;

ACID-BASE EQUILIBRIUM; ANIMALS; BLOOD DONORS; BLOOD PRESSURE; CALCIUM; CITRIC ACID; DOGS; ELECTROCARDIOGRAPHY; FEASIBILITY STUDIES; FEMALE; GLUCONATES; HYPOCALCEMIA; MALE; PLATELETPHERESIS;

EID: 52949083879     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/j.1537-2995.2008.01803.x     Document Type: Article

References (25)

1. Vassallo RR Jr., Wahab F, Giordano K, Murphy S. Improving technology for collecting platelets by apheresis: five year experience in one blood center. Transfus Med Rev 2004 18 : 257 66.
2. Slichter SJ, O'Donnell MR, Weiden PL, Storb R, Schroeder ML. Canine platelet alloimmunization: the role of donor selection. Br J Haematol 1986 63 : 713 27.
3. Slichter SJ, Deeg HJ, Kennedy MS. Prevention of platelet alloimmunization in dogs with systemic cyclosporine and by UV-irradiation or cyclosporine-loading of donor platelets. Blood 1987 69 : 414 8.
4. Slichter SJ, Fish D, Abrams VK, Gaur L, Nelson K, Bolgiano D. Evaluation of different methods of leukoreduction of donor platelets to prevent alloimmune platelet refractoriness and induce tolerance in a canine transfusion model. Blood 2005 105 : 847 54.
5. Bolan C, Greer S, Cecco S, Oblitas JM, Rehak NN, Leitman SF. Comprehensive analysis of citrate effects during plateletpheresis in normal donors. Transfusion 2001 41 : 1165 71.
6. Seeler DC. Fluid, electrolyte, and blood component therapy. In : Tranquilli WJ, Thurmon JC, Grimm KA, editors. Lumb and Jones' veterinary anesthesia and analgesia, 4th ed. Ames (IA) : Blackwell Publishing 2007. p. 185 210.
7. Bueno JL, Barea L, Garcia F, Castro E. A comparison of PLT collections from two apheresis devices. Transfusion 2004 44 : 119 24.
8. Buchholz DH, Squires JE, Herman JH, Ng AT, Anderson JK, Hedberg SL. Plateletpheresis in 90- to 110-pound donors using the CS-3000 blood cell separator. Transfusion 1997 37 : 715 8.
9. Warty VS, Busch RP, Virji MA. A kit for citrate foodstuffs adapted for assay of serum and urine. Clin Chem 1984 30 : 1231 3.
10. Williams DA, Maggio-Price L. Canine idiopathic thrombocytopenia: clinical observations and long-term follow-up in 54 cases. J Am Vet Med Assoc 1984 185 : 660 3.
11. Hale AS, Lucas RL, Davis JM. Production of canine platelet concentrates by an automated apheresis technique [abstract]. J Vet Intern Med 2000 14 : 380.
12. Hale AS, Lucas RL. A comparison of complications resulting from apheresis or whole blood collection in dogs [abstract]. Transfusion 2005 45 Suppl : 48S.
13. Williamson KD, Hale AS. Biochemical abnormalities associated with plateletpheresis [abstract]. J Vet Emerg Crit Care 2007 17 : S12.
14. Bolan CD, Yau YY, Cullis HC, Horwitz ME, Mackall CL, Barrett AJ, Malech HL, Rehak NN, Wayne AS, Leitman SF. Pediatric large-volume leukapheresis: a single institution experience with heparin versus citrate-based anticoagulant regimens. Transfusion 2004 44 : 229 38.
15. Buchta C, Macher M, Bieglmayer C, Höcker P, Dettke M. Reduction of adverse citrate reactions during autologous large-volume PBPC apheresis by continuous infusion of calcium gluconate. Transfusion 2003 43 : 1615 21.
16. Bolan CD, Cecco SA, Wesley RA, Horne M, Yau YY, Remaley AT, Childs RW, Barrett AJ, Rehak NN, Leitman SF. Controlled study of citrate effects and response to IV calcium administration during allogeneic peripheral blood progenitor cell donation. Transfusion 2002 42 : 935 46.
17. Bolan CD, Wesley RA, Yau YY, Cecco SA, Starling J, Oblitas JM, Rehak NN, Leitman SF. Randomized placebo-controlled study of oral calcium carbonate administration in plateletpheresis: I. Associations with donor symptoms. Transfusion 2003 43 : 1403 13.
18. Bolan CD, Cecco SA, Yau YY, Wesley RA, Oblitas JM, Rehak NN, Leitman SF. Randomized placebo-controlled study of oral calcium carbonate supplementation in plateletpheresis: II. Metabolic effects. Transfusion 2003 43 : 1414 22.
19. Haddad S, Leitman SF, Wesley RA, Cecco S, Yau YY, Starling J, Rehak NN, Bolan CD. Placebo-controlled study of intravenous magnesium supplementation during large-volume leukapheresis in healthy allogeneic donors. Transfusion 2005 45 : 934 44.
20. Kishimoto M, Ohto H, Shikama Y, Kikuta A, Kimijima I, Takenoshita S. Treatment for the decline of ionized calcium levels during peripheral blood progenitor cell harvesting. Transfusion 2002 42 : 1340 7.
21. Das SS, Chaudhary R, Khetan D, Shukla JS, Agarwal P, Mishra RB. Calcium and magnesium levels during automated plateletpheresis in normal donors. Transfus Med 2005 15 : 233 6.
22. Mercan D, Bastin G, Lambermont M, Dupont E. Importance of ionized magnesium measurement for monitoring of citrate-anticoagulated plateletpheresis. Transfusion 1997 37 : 418 22.
23. Dzik S, Moroff G, Dumont L. A multicenter study evaluating three methods for counting residual WBCs in WBC-reduced blood components: Nageotte hemocytometry, flow cytometry, and microfluorometry. Transfusion 2000 40 : 513 20.
24. Bode AP, Lust RM, Read MS, Fischer TH. Correction of the bleeding time with lyophilized platelet infusions in dogs on cardiopulmonary bypass. Clin Appl Thromb Hemost 2008 14 : 38 54.
25. Wandall HH, Hoffmeister KM, Sorenson AL, Rumjantseva V, Clausen H, Hartwig JH, Slichter SJ. Galactosylation does not prevent the rapid clearance of long-term, 4°C-stored platelets. Blood 2008 111 : 3249 56.